Unravelling Hematological Disorders Using Targeted NGS Panels

Unravelling Hematological Disorders Using Targeted NGS Panels

Prof. Dr. Dr. Torsten Haferlach, Head of Cytomorphology, MLL Munich Leukemia Laboratory
Topic: Cancer Genomics

Prof. Torsten Haferlach, Head of MLL Munich Leukemia Laboratory, will discuss how their laboratory has implemented NGS technology for sequencing targeted gene panels.

 

Join in to hear about

·       Application of NGS to molecular pathology assessment of hematological malignancies

·       Integrated process for data analysis and reporting results

 

Join the live webinar event and participate in the Q&A session!



Introducing Nextera™ Flex for Enrichment
Grace DeSantis, Ph.D. Director, Product Development, Illumina, Inc.
Topic: Cancer Genomics : Human Genetics & Genetic Disease
IASLC 2019 Targeted Therapies of Lung Cancer Meeting
Santa Monica, CA | North America
Topic: Cancer Genomics
Advances in Genome Biology and Technology (AGBT) Annual Meeting 2019
Marco Island, FL | North America
Topic: Agriculture Genomics : Cancer Genomics : Forensic Genomics : Reproductive & Genetic Health : Human Genetics & Genetic Disease : Microbiology & Infectious Disease : HLA Typing